PA Medical News about Epilepsy, Complex Partial Epilepsy, Partial, Motor Epilepsy, Partial, Sensory Carisbamate

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Use of Antiemetic Agents in Acute Gastroenteritis

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Carisbamate as adjunctive treatment of partial onset seizures in adults in two randomized, placebo-controlled trials
Epilepsia, 10/29/09

Sperling MR et al. – Carisbamate 400 mg/day was effective in patients with refractory partial–onset seizures in one of these global studies. More than 200 mg/day of carisbamate is required for efficacy. Carisbamate was well–tolerated in both studies.

Pathologic cardiac repolarization in pharmacoresistant epilepsy and its potential role in sudden unexpected death in epilepsy: A case–control study
Epilepsia, 10/21/09 Relevance Score: 98%

Oxcarbazepine versus carbamazepine monotherapy for partial onset seizures
Cochrane Reviews, 10/09/09 Relevance Score: 97%

Treatment of refractory complex partial seizures: role of vigabatrin
Neuropsychiatric Disease and Treatment, 10/08/09 Relevance Score: 97%

Focal clinical and electroencephalographic features in patients with juvenile myoclonic epilepsy
Acta Neurologica Scandinavica, 10/22/09 Relevance Score: 96%

Positive syndrome of schizophrenia and epilepsy
Medical Hypotheses, 10/08/09 Relevance Score: 96%